Tag Archive for: STTR

SBIR/STTR programs will expire if Congress doesn’t reauthorize by September 30th. Senator Paul blocked reauthorization because of security problems. New provisions added to address security concerns.
Bill passed Senate, expected to pass House. SBIR/STTR programs extended for three more years.

SBIR/STTR programs could expire Sept 30. Reauthorization opposed by Rand Paul and others. SBIR/STTR grants enable commercialization of federally funded research and have broad benefits that improve life for all Americans as well as billions around the globe.

Dr. William Bozza discusses non-dilutive funding opportunities at NCI and NIH.

Dr. Charles L. Cywin discusses non-dilutive funding opportunities at NINDS and NIH.

Dr. Daniel Gossett discusses non-dilutive funding opportunities at NIDDK and NIH.

Dr. Abla Creasey discusses non-dilutive funding opportunities at the California Institute for Regenerative Medicine, which funds stem cell R&D.